Second and Third Generation Plague Vaccines

  • Richard W. Titball
  • E. Diane Williamson
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 529)


A defined sub-unit vaccine against plague now seems to be feasible. The further development of this vaccine will be dependent on clinical trials with this vaccine. In parallel, there is good reason to believe that next-generation vaccines, will be given orally or intranasally.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anderson, G.W. Jr., Leary, S.E.C., Williamson, E.D., Titball, R.W., Welkos, S.L., Worsham, P.L. and Friedlander, A.M., 1996, Recombinant V antigen protects mice against pneumonic and bubonic caused by F1-capsule-positive and-negative strains of Yersinia pestis. Infect. Immun. 64: 4580–4585.PubMedGoogle Scholar
  2. Andrews, G.P., Strachan, S.T., Benner, G.E., Sample, A.K., Anderson, G.W., Adamovicz, J.J., Welkos, S.L., Pullen, J.K., Friedlander, A.M., 1999, Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis. Infect. Immun. 67: 1533–1537.PubMedGoogle Scholar
  3. Bartelloni, P.J., Marshall, J.D., Cavanaugh, D.C., 1973, Clinical and serological responses to plague vaccine. Mil. Med. 138: 720–722.PubMedGoogle Scholar
  4. Carr, S., Miller, J., Leary, S.E.C., Bennett, A.M., Ho, A and Williamson, E.D., 1999, Expression of a recombinant form of the V antigen of Yersinia pestis using three different expression systems. Vaccine 18: 153–159.CrossRefPubMedGoogle Scholar
  5. Du, Y., Rosqvist, R., Forsberg, A., 2002, Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect. Immun. 70: 1453–1460.CrossRefPubMedGoogle Scholar
  6. Easterbrook, T.J., Reddin, K., Robinson, A., Modi, N., 1995, Studies on the immunogenicity of the Pla protein from Yersinia pestis. Contrib. Microbiol. Immunol. 13: 214–215.PubMedGoogle Scholar
  7. Eyles, J.E., Williamson, E.D., Spiers, I.D., Stagg, A.J., Jones, S.M. and Alpar, H.O., 2000, Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant sub-units. J. Cont. Rel. 63: 191–200.Google Scholar
  8. Eyles, J.E., Bramwell, V.W., Williamson, E.D. and Alpar, H.O., 2001, Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration. Vaccine 19: 4732–4742.CrossRefPubMedGoogle Scholar
  9. Galimand, M., Guiyoule, A., Gerbaud, G., Rasoamanana, B., Chanteau, S., Carniel, E., Courvalin, P., 1997, Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N. Engl. J. Med. 337: 677–680.CrossRefPubMedGoogle Scholar
  10. Green, M., Rogers, D., Russell, P., Stagg, A.J., Bell, D.L., Eley, S.M., Titball, R.W., Williamson, E.D., 1999, The SCID/Beige mouse as a model to investigate protection against Yersinia pestis. FEMS Immunol. Med. Microbiol. 23: 107–113.PubMedGoogle Scholar
  11. Hill, J., Leary, S.E.C., Griffin, K.F., Williamson, E.D. and Titball, R.W., 1997, Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunisation. Infect. Immun. 65: 4476–4482.PubMedGoogle Scholar
  12. Jones, S.M., Griffin, K.F., Hodgson, I. and Williamson, E.D., 2002, Protective efficacy of a fully recombinant plague vaccine in the guinea pig. Vaccine, submitted.Google Scholar
  13. Leary, S.E.C., Williamson, E.D., Griffin, K.F., Russell, P., Eley, S.M and Titball, R.W., 1995, Active immunisation with recombinant V antigen from Yersinia pestis protects mice against plague. Infect. Immun. 63: 2854–2858.PubMedGoogle Scholar
  14. Leary, S.E.C., Griffin, K.F., Garmory, H.S., Williamson, E.D. and Titball, R.W., 1997, Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. Microb. Pathog. 23: 167–179.PubMedGoogle Scholar
  15. Leary, S.E.C. and Titball, R.W., 1998, Plague. Brit. Med. Bull. 54: 625–633.PubMedGoogle Scholar
  16. Leary, S.E.C., Griffin, K.F., Galyov, E., Hewer, J., Williamson, E.D., Hölmström, A., Forsberg, A. and Titball, R.W., 1999, Yersinia outer proteins (YOPS) E,K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague. Microb. Pathog. 26: 159–169.PubMedGoogle Scholar
  17. Meyer, K.F., 1970, Effectiveness of live or killed plague vaccines in man. Bull. World Health Organ. 42: 653–666.PubMedGoogle Scholar
  18. Meyer, K.F., and Foster, L.E., 1948, Measurement of protective serum antibodies in human volunteers inoculated with plague prophylactics. Stanford Med. Bull. 6: 75–79.Google Scholar
  19. Miller, J., Williamson, E.D., Lakey, J.H., Pearce, M.J., Jones, S.M., and Titball, R.W., 1998, Macromolecular organisation of recombinant Yersinia pestis F1 antigen and the effect of structure on immunogenicity. FEMS Immunol. Med. Microbiol. 21: 213–221.PubMedGoogle Scholar
  20. Montie, T.C., and Montie, D.B., 1971, Protein toxins of Pasturella pestis. Subunit composition and acid binding. Biochemistry 10: 2094–2100.CrossRefPubMedGoogle Scholar
  21. Nakajima, R., Motin, V.L., and Brubaker, R.R., 1995, Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect. Immun. 63: 3021–3029.PubMedGoogle Scholar
  22. Nemeth, J., and Straley, S.C., 1997, Effect of Yersinia pestis YopM on experimental plague. Infect. Immun. 65: 924–930.PubMedGoogle Scholar
  23. Payne, D.W., Oyston, P.C.F., and Williamson, E.D., Immunisation with pH6 antigen in the mouse is not protective (unpublished data).Google Scholar
  24. Pettersson, J., Holmström, A., Hill, J., Leary, S., Frithz-Lindsten, E., von Euler-Matell, A., Carlsson, E., Titball, R.W., Forsberg, A. and Wolf-Watz, H., 1999, The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol. Microbiol. 32: 961–976.CrossRefPubMedGoogle Scholar
  25. Prior, J., Hitchin, P.G., Wiliamson, E.D., Reason, A.J., Morris, H.R., Dell, A., Wren, B. and Titball, R.W., 2001, Characterisation of the lipopolysaccharide of Yersinia pestis. Microbial. Pathog. 30: 49–57.Google Scholar
  26. Russell, P, Eley, S.M., Hibbs, S.E., Manchee, R.J., Stagg, A.J. and Titball, R.W., 1995, A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13: 1551–1556.PubMedGoogle Scholar
  27. Simpson, W.J., Thomas, R.E., and Schwan, T.G., 1990, Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice. Am. J. Trop. Med. Hyg. 43: 389–396.PubMedGoogle Scholar
  28. Titball, R.W., Howells, A.M., Oyston, P.C.F., Williamson, E.D., 1997, Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high level protection against plague. Infect. Immun. 65: 1926–1930.PubMedGoogle Scholar
  29. Titball, R.W., Eley, S., Williamson, E.D., and Dennis, D.T., 1999, Plague. In Vaccines (S.A. Plotkin and W.A. Orenstein, eds.), W.B. Saunders Company, Philadelphia, pp.734–742.Google Scholar
  30. Titball, R.W. and Williamson, E.D., 2001, Vaccination against bubonic and pneumonic plague. Vaccine 19: 4175–4184.CrossRefPubMedGoogle Scholar
  31. Tito, M.A., Miller, J., Griffin, K.F., Williamson, E.D., Titball, R.W. and Robinson, C.V., 2001, Macromolecular organisation of the Yersinia pestis capsular F1-antigen: insights from time of flight mass spectrometry. Prot. Sci. 10: 2408–2413.Google Scholar
  32. Von Metz, E., Eisler, D.M., Hottle, G.A., 1971, Immunogenicity of plague vaccines in mice and guinea pigs. Appl. Microbiol. 22: 84–88.Google Scholar
  33. Weeks, S., Hill, J., Friedlander, A., Welkos, S., 2002, Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis. Microb. Pathog. 32: 227–237.PubMedGoogle Scholar
  34. Williamson, E.D., Eley, S.M., Griffin, K.F., Green, M., Russell, P., Leary, S.E.C., Oyston, P.C.F., Easterbrook, T., Reddin, K.M., Robinson, A. and Titball, R.W., 1995, A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol. Med. Microbiol. 12: 223–230.PubMedGoogle Scholar
  35. Williamson, E.D., Eley, S.M., Stagg, A.J., Green, M., Russell, P., Titball, R.W., 1997, A subunit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunised animals against pneumonic plague. Vaccine 15: 1079–1084.CrossRefPubMedGoogle Scholar
  36. Williamson, E.D., Vesey, P.M., Gillhespy, K.J., Eley, S.M., Green, M. and Titball, R.W., 1999, An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin. Exp. Immunol. 116: 107–114.CrossRefPubMedGoogle Scholar
  37. Williamson, E.D., Eley, S.M. Stagg, A.J., Green, M., Russell, P and Titball, R.W., 2001, A single dose sub-unit vaccine protects against pneumonic plague. Vaccine 19: 566–571.Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Richard W. Titball
    • 1
  • E. Diane Williamson
    • 1
  1. 1.Defence Science and Technology LaboratorySalisburyUK

Personalised recommendations